Home › Funds › Commodore Capital LP › ZURA

Commodore Capital LP position in ZURA

ZURA BIO · Health Care

Commodore Capital LP reported holding 3,250,000 shares of ZURA (ZURA BIO) in its Q2 2026 13F filing — a position valued at US$19.2M, representing 1.14% of its reported portfolio and ranking #21 among its reported holdings. Commodore Capital LP has disclosed ZURA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)3.25M sh
Reported value held$19.18M
Portfolio Weight1.14%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's ZURA position evolved

Commodore Capital LP first disclosed a stake in ZURA in Q1 2026 at 3,250,000 shares (US$19.3M). Across 2 filings, Commodore Capital LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,250,000 shares valued at US$19.2M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 3.25M $19.34M New
Q2 2026 3.25M $19.18M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZURA and 13F data

ZURA (ZURA BIO) is a Health Care company. 52 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$55.7M), Venrock Adviser, LLC (US$38.0M), MPM BioImpact LLC (US$26.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZURA

All ZURA fund holders →

FAQ

How long has Commodore Capital LP held ZURA?

Commodore Capital LP has disclosed ZURA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Commodore Capital LP's current position in ZURA?

As of Q2 2026, Commodore Capital LP holds 3.25M shares of ZURA (ZURA BIO), valued at $19.18M, representing 1.14% of its reported portfolio and ranking #21.

Has Commodore Capital LP been buying or selling ZURA?

In the latest 13F filing (Q2 2026), Commodore Capital LP held unchanged its position in ZURA.

Which other funds hold ZURA?

Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.